Eleftha 440 mg Injection
232,11$
184,66$
Eleftha 440 mg Injection is a targeted therapy designed for the management of metastatic breast cancer and metastatic gastric cancer, specifically in patients whose tumors overexpress the HER2/neu receptor. This monoclonal antibody works by selectively binding to the HER2 protein on the surface of cancer cells, effectively inhibiting their growth and proliferation. By disrupting the signaling pathways that promote tumor development, Eleftha helps to slow down disease progression and improve treatment outcomes. While this medication can be a crucial part of cancer therapy, it's important to be aware of potential side effects, including fatigue and infusion-related reactions. Patients receiving Eleftha should be monitored closely for any adverse effects and have regular assessments to evaluate their response to treatment. As with any cancer treatment, it's essential to discuss the risks and benefits with a healthcare provider to ensure optimal management. Eleftha 440 mg Injection represents a significant advancement in targeted cancer therapies, offering hope for improved survival rates in patients battling aggressive forms of cancer.
Quantité
Active Pharmaceutical Ingredient
Uses
• Eleftha 440 mg injection is utilized in the management of stomach cancer, a malignancy that originates in the stomach lining. Patients may experience various symptoms such as abdominal pain, weight loss, and nausea. The medication aids in reducing the risk of disease progression and supports overall treatment strategies. Healthcare providers may recommend Eleftha 440 mg injection as part of a comprehensive care plan.
• In addition to its role in stomach cancer, Eleftha 440 mg injection is also indicated for breast cancer treatment. This type of cancer arises from the cells in breast tissue and can manifest through symptoms like unusual lumps or changes in breast appearance. By administering Eleftha 440 mg injection, healthcare professionals aim to enhance patient outcomes and manage the disease more effectively. It serves as a valuable option in the therapeutic arsenal against breast cancer.
• Eleftha 440 mg injection is employed in various cancer treatment regimens to support patients facing significant challenges. Its mechanism of action may help in controlling tumor growth and improving quality of life for individuals diagnosed with cancer. This injection is often given in conjunction with other therapies, reflecting its role in a multidisciplinary approach to cancer care. Patients receiving Eleftha 440 mg injection can expect close monitoring and tailored treatment plans.
• The use of Eleftha 440 mg injection extends to scenarios where cancer treatment requires a robust adjunct therapy. It is particularly beneficial for patients with advanced stages of stomach or breast cancer, where traditional therapies may need enhancement. By incorporating Eleftha 440 mg injection, clinicians strive to optimize therapeutic outcomes and provide a more comprehensive treatment experience. This injection plays a significant role in the ongoing fight against cancer.
Benefits
Breast cancer: Eleftha 440 mg Injection is used for the treatment of breast cancer when there has been no significant improvement with other medicines. It helps stop the growth and spread of the cancer, and relieves symptoms of breast cancer, such as lumps in the breast, nipple discharge, or changes in the shape or texture of the breast. A doctor or nurse will give this medicine by injection. To get the most benefit, follow your doctor's instructions carefully.
Stomach cancer: Stomach cancer, also known as gastric cancer, can occur in the inner lining (called the lining) of the stomach or in the walls of the stomach. There are different types of stomach cancer depending on where it starts, the area affected and the severity of the cancer. Eleftha 440 mg helps kill cancer cells and stop them from growing and spreading. To get the most benefit, follow your doctor's instructions carefully.
Side Effects
Like all medicines, Eleftha 440 mg Injection may cause side effects that do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Infection
• Fever
• Weight Loss
• Appetite Loss
• Skin Rashes
• Constipation
• Reduce in Blood Count
• Heartburn
• Runny nose
• Hair Loss
• Muscle and Joint Pain
Common Side Effects
• Congestive heart failure
• Lung problems
• Trouble in breathing
• Fluid in the lungs
How To Use
Eleftha 440 Injection is an intravenous infusion, administered under the supervision of your doctor or a nurse in a hospital. Self-administration is not recommended to the patient.
Safety Advice
• Alcohol: Drinking alcohol while taking Eleftha 440 Injection is generally not recommended. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol intake while taking any medication.
• Kidney: It is safe to use Eleftha 440 Injection in patients with kidney disease. No dose adjustment of Eleftha 440 mg Injection is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Eleftha 440 Injection. Eleftha 440 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Eleftha 440 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Eleftha 440 Injection is safe for use in patients with mild to moderate liver disease, no dose adjustment of Eleftha 440 mg Injection is recommended. The use of Eleftha 440 mg Injection is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Eleftha 440 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Eleftha 440 Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Eleftha 440 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Eleftha 440 Injection.